DeNA Co. (2432) investor relations material

Executive summary

• Q3 FY2025 revenue was 31.3 billion yen, down 33% year-over-year and 24% quarter-over-quarter, with IFRS operating profit at -8.1 billion yen and Non-GAAP operating profit at 2.1 billion yen, reflecting a significant impairment loss on goodwill related to Allm.

• Revenue for the nine months ended December 31, 2025 was ¥114,452 million, down 1.9% year-over-year, with operating profit at ¥16,895 million, down 19.5% year-over-year, and profit attributable to owners of the parent at ¥16,821 million, up 6.8% year-over-year.

• Upward revision to Non-GAAP operating profit guidance for FY2025 due to business progress, while IFRS operating profit guidance was revised downward due to impairment losses.

• Cost of sales and SG&A expenses both declined, while impairment losses of ¥9,912 million were recorded, mainly related to goodwill in the Healthcare & Medical Business.

• Share of profit of associates rose sharply, driven by strong performance from Cygames, Inc. and GO Inc.

Financial highlights

• Revenue for Q3 FY2025: 31.3 billion yen (YOY: -33%, QoQ: -24%).

• IFRS operating profit: -8.1 billion yen (PY Q3: 15.5 billion yen, Q2: 11.1 billion yen).

• Non-GAAP operating profit: 2.1 billion yen (YOY: -86%, QoQ: -81%).

• Basic earnings per share increased to ¥150.91 from ¥141.48 year-over-year.

• Cash and cash equivalents increased to ¥97,531 million, up ¥4,729 million from the previous fiscal year end.

Outlook and guidance

• FY2025 revenue guidance revised to 146.5 billion yen (down 4.9% from previous forecast).

• IFRS operating profit guidance revised to 17.0 billion yen (down 32%), Non-GAAP operating profit guidance raised to 26.5 billion yen (up 9.1%).

• Commitment to Non-GAAP operating profit of 15.0 billion yen for FY2026 remains unchanged.

• Dividend per share for the fiscal year ending March 31, 2026 is forecast at ¥66, reflecting a policy change and increase.